AbbVie (ABBV) Assets (2012 - 2026)

AbbVie (ABBV) has 15 years of Assets data on file, last reported at $136.5 billion in Q1 2026.

• Assets for Q1 2026 came in at $136.5 billion, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $136.5 billion (changed 0.22% YoY), and the FY2025 annual result was $134.0 billion, down 0.89% from the prior year.
• Assets improved to $136.5 billion in Q1 2026 per ABBV's latest filing, from $134.0 billion in the prior quarter.
• Over five years, Assets peaked at $148.9 billion in Q1 2024 and troughed at $133.9 billion in Q3 2025.
• A 5-year average of $138.5 billion and a median of $136.5 billion in 2026 frame the typical range for Assets.
• The sharpest annual moves came in 2024 and 2025: Assets increased 10.65% in 2024, then retreated 8.54% in 2025.
• A 5-year view of Assets shows it stood at $138.8 billion in 2022, then decreased by 2.95% to $134.7 billion in 2023, then climbed by 0.33% to $135.2 billion in 2024, then dropped by 0.89% to $134.0 billion in 2025, then grew by 1.87% to $136.5 billion in 2026.
• Business Quant data shows ABBV's Assets at $136.5 billion in Q1 2026, $134.0 billion in Q4 2025, and $133.9 billion in Q3 2025.